Digitising the cell to discover new drugs
Engine Biosciences uses data analytics and machine learning to speed up the discovery of new drugs.
Add BT as a preferred source
THE current state of medical technology has meant that despite there being some 20,000 genes in the human genome, the standard procedure for drug discovery is to laboriously measure the effect of a test drug on a single or pair of genes one by one.
Each individual or pair of genes has to be examined, which would theoretically mean conducting an excess of 20,000 tests for individual genes, and an additional 400 million tests for pairs of genes.
The trial-and-error approaches have been summarised by Engine Biosciences co-founder and chief executive officer Jeffrey Lu as: brute-force hacking or old-fashioned quests.
TRENDING NOW
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
